This is a provisional file, not the final typeset article Biomaterials have shown significant potential in various biomedical fields, including disease prevention, theranostics, and tissue regeneration by controlled delivery of therapeutics, contrast agents, sensing agents, growth factors, and so forth. In recent years, Asian scientists have contributed more to biomaterials with the increasing support of various funds. Through this Research Topic, we expected to collect several state-of-the-art advances in biomaterial science and engineering research within Asia and disseminate them to the global audience. This Research Topic comprised 35 articles (including 7 reviews, 27 original research articles, and 1 case report) contributed by 263 authors, and it has attracted 51,307 views, 11,074 downloads, and 27 citations by researchers worldwide up to January 2, 2022.Undoubtedly, this Research Topic has won great success in displaying the significant contributions of Asian scientists to next-generation precision medicine and further clinical translation.The reviews from this Research Topic have covered the latest progress in several different types of biomaterials for diverse biomedical applications, including intraocular lens materials and their surface modification for cataract surgery [1], drug delivery systems for the treatment of autoimmune diseases [2] and intervertebral disc degeneration [3], and engineering exosomes for bone defect repair [4]. Also, anti-biofouling polymer materials with special surface wettability and their biomedical applications are summarized [5]. Particularly, this research topic included two review papers about the recent development of organ-on-a-chips, regarding the application of medical imaging methods and artificial intelligence [6] and physiologically based pharmacokinetic (PBPK) modeling [7]. These wellorganized reviews would provide the readers with an overview and constructive perspectives of these specific topics of biomaterials.The original research articles on this Research Topic have contributed to several critical aspects of biomaterials, including the preparation, characterizations, biological functions/mechanisms, and practical applications in clinic.Smart biomaterials have shown distinct and adjustable in vivo behaviors for the delivery of therapeutic agents, such as small-molecule drugs, genes, and proteins, which is promising to improve the limitations of such therapeutics in clinic, including the low solubility/stability, short circulation, unsatisfactory selectivity on target tissues, and so forth. For example, cancer cell membrane-coated biomimetic mesoporous organosilica nanoparticles improved the anticancer performance and decreased the in vivo system toxicity of cisplatin because it prolonged the circulation time and increased tumor accumulation [8]. Jiang et al. [9] demonstrated that micelles containing 15-crown-5 selectively released the loaded curcumin in response to the intracellular potassium ion (K + ) by forming the 2:1 ''sandwich'' host-guest complexes between 15-crown-5 and K + . Similarly, an amphiphilic micelle comprised of a Y-shaped polypeptide has demonstrated excellent drug loading and release behavior [10]. Interestingly, a carrier-free nanodrug composed of ginsenosides Rg3 and Rb1 has shown better antitumor and antimetastatic effects against triple-negative breast cancer than the direct combination of free drugs [11]. In addition, a cyclic Arg-Gly-Asp (cRGD)-decorated liposome loading with urokinase has shown enhanced thrombolytic effects by active targeting delivery of urokinase to the thrombi [12]. Sun et al. [13] developed electroactive shape memory polymers based on polyurethane and carbon nanotubes, which would be employed as four-dimensional (4D)-printing materials for potential biomedical applications. Some biomaterials have shown capacities to manipulate the behaviors of cells. For example, graphene was proven to promote the differentiation of Lgr5+ progenitors into inner ear hair cells [14].Besides, copper-lithium-doped nanohydroxyapatite promoted the migration and homing of mesenchymal stem cells (MSCs) by upregulating the hypoxia-inducible factor 1α/stromal cell-derived factor-1 (HIF-1α/SDF-1) pathway [15]. Interestingly, increasing the viscoelastic properties of cellulose nanocrystal/collagen hydrogels promoted the proliferation, alteration of shape, and matrix deposition of chondrocytes and reduced the interleukin-1β (IL-1β) secretion [16]. Moreover, Xia et al. [17] developed magnetic nano chains, which guided the oriented growth of neural stem cells-derived neurons. Zhang et al. [18] demonstrated that a conductive hybrid hydrogel promoted the development of neural stem cells into neurons. Wang et al. [19] indicated that epigallocatechin-3-gallate selenium nanoparticles scavenged reactive oxygen species (ROS) effectively and thus provided superior neuroprotective effects. Qin et al. [20] demonstrated intimate interactions among innervation, angiogenesis, and inflammation in the condylar cartilage of temporomandibular joint osteoarthritis, which provided promising treatment targets. Except for developing advanced biomaterials, the surface modification of materials is also a method to obtain biomaterials with specific functions. For example, coating 316L stainless steel with glycogen synthase kinase-3β inhibitor (GSKi) improved the adhesion and proliferation of human coronary artery endothelial cells [21]. Such properties of these biomaterials made them promise to treat various diseases, such as sensory hearing loss, osteonecrosis, osteoarthritis, neurodegenerative disorders, cerebral ischemia-reperfusion injury, and cardiovascular diseases.In the past several decades, tissue engineering and regenerative medicine have emerged as essential branches of biomaterials. Several impressive research articles have provided constructive insights into the current Research Topic. Fu et al. [22] performed a systemic bibliometric and visualized analysis regarding the photosensitive hydrogels for tissue engineering. Qin et al. [23] established a "click" reaction-based method for surface modification of polycaprolactone scaffold, which could be utilized in the long-term controlled release of multiplex signal proteins for tissue engineering. Zhang et al. [24] developed a polydopamine-poly(lactic-co-glycolic acid) (PDA-PLGA) scaffold carrying RINm5f islet This is a provisional file, not the final typeset article cells, which supported the growth of islet cells and showed no influence on insulin secretion. When the type I diabetic rats were transplanted with the scaffold in the skeletal muscles, their blood glucose was maintained at a low level for approximately three weeks.As emerging multipotential natural biomaterials, exosomes and secretomes have exhibited bright prospects in regenerative medicine. Particularly, scaffolds containing engineered exosomes derived from adipose-derived mesenchymal stem cells (A-MSCs) under hypocapnia [25] and hypoxiapretreated MSCs [26] or secretomes derived from basic fibroblast growth factor (bFGF)-pretreated human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) [27] have significantly facilitated the neural regeneration, which demonstrated great promise in the treatment of traumatic brain injury and the functional recovery after surgical treatment.Biomaterials are also developed as sensitive detectors or contrast agents for disease diagnostics and identification of microbes/biomolecules. For example, Lin et al. [28] reported PDA-coated silicon quantum dots as fluorescent probes of bacteria and their biofilms. Selective labeling of gram-positive and gram-negative bacteria was achieved by altering the surface functionalization groups. Besides, Liu et al. [29] developed a visual and temperature-sensitive probe to detect microRNA, which could be biomarkers of diverse diseases like cancer. This biosensor enables point-of-care detection of biomolecules with low cost, ease of operation, and high sensitivity.Clinical applications and translations are the terminal goals of the development of biomaterials.The unique or modified biomaterials and biotechnologies should benefit more patients only when they pass the reliability assessment and model validation. Sun et al. [30] provided an updated design of percutaneously osseointegrated prostheses for amputees, in which new bone formation at the boneimplant-skin opening area and the distal bone canal was observed. For dental materials, Liang et al. [31] demonstrated that the hot etching of zirconia with hydrofluoric acid (HF) induced a more uniform and dense porous morphology, greater roughness, and provided the highest shear bond strength. In addition, a multicenter retrospective study has demonstrated the high efficiency of ultrasound-guided percutaneous thermal ablation in the clinical treatment of hepatic focal nodular hyperplasia [32].Notably, the severe side effects of some medicines have limited their broad applications, although they are approved for clinical use. This Research Topic also reports strategies to reduce the side effects of clinically used therapeutics. Lan et al. [33] developed acitretin-conjugated dextran nanoparticle (ACT-Dex NP), which achieved a similar therapeutic effect on psoriasis-like skin disease at a significantly lower dosage compared to neat acitretin. This low dosage is promising to avoid acitretin's well-known teratogenicity on fetuses. Moreover, Zhang et al. [34] demonstrated that the neomycininduced ototoxicity would be prevented by combination with tetrandrine (a bioactive bisbenzylisoquinoline alkaloid derived from Stephania tetrandra) by promoting the steroid biosynthesis.This Research Topic also included a rare case report in clinic [35]. The authors reported a patient with an uncommon pseudoaneurysm, involving the left common iliac artery because of brucellosis. A favorable therapeutic effect and well prognosis were obtained with a combination treatment of longterm multi-course antibacterial therapy with combination antibiotics. This report would provide a paradigm for the clinical treatment of such diseases.In summary, this Research Topic encompasses a proportion of critical contributions made by Asian researchers in the biomaterial field in recent years. This regionalized issue showed the rapid development of biomaterials in Asia, and it is foreseeable that Asian scientists will play a more significant role in this field in the future.
8 Authors
- XL
Xiaoyin Liu
Department of Neurosurgery, China
- JW
Jingjing Wang
Tianjin Key Laboratory of Neurotrauma Repair, China
- PW
Peng Wang
Department of Health Management, China
- LZ
Lin Zhong
The First Affiliated Hospital of Chengdu Medical College, China
- SW
Shan Wang
Department of Neurosurgery, China
- QF
Qingbo Feng
Department of Liver Surgery and Liver Implantation, China
- XW
Xin Wei
Department of Urology, China
- LZ
Liangxue Zhou
Department of Neurosurgery, China
5 Authors
- YW
Yiming Wang
Department of Orthopaedic Surgery, China
- WL
Wenqi Luo
Department of Orthopaedic Surgery, China
- FL
Feng Lin
Department of Orthopaedic Surgery, China
- WL
Wanguo Liu
Department of Orthopaedic Surgery, China
- RG
Rui Gu
Department of Orthopaedic Surgery, China
4,816 views
32 citations
10 Authors
- ZL
Zhuoran Liang
Department of Stomatology, China
- YL
Yang Liu
Department of Stomatology, China
- YJ
Yulin Jiang
Department of Stomatology, China
- PL
Pan Liu
Department of Stomatology, China
- YZ
Yannan Zhang
Department of Stomatology, China
- FM
Fanhao Meng
Department of Stomatology, China
- ML
Min Liu
Department of Stomatology, China
- ZC
Zhi Cui
Department of Stomatology, China
- JM
Jinbao Ma
Department of Stomatology, China
- JC
Jianfeng Chen
Department of Stomatology, China
6,977 views
6 citations
7 Authors
- YS
Yadong Sun
Research Institute for Biomaterials, China
- JT
Jiachi Teng
Research Institute for Biomaterials, China
- YK
Yi Kuang
College of Chemical and Materials Engineering, China
- SY
Shengxiang Yang
College of Chemical and Materials Engineering, China
- JY
Jiquan Yang
Nanjing Industry Institute for Advanced Intelligent Equipment, China
- HM
Hongli Mao
Research Institute for Biomaterials, China
- ZG
Zhongwei Gu
Research Institute for Biomaterials, China
4,898 views
15 citations
10 Authors
- MZ
Meishuang Zhang
Department of Pharmacology, China
- HD
Hongwei Du
Research Institution of Paediatrics, China
- YG
Yueqi Guan
Department of Pharmacology, China
- JL
Jingyue Liu
Department of Pharmacology, China
- SW
Sushan Wang
Department of Pharmacology, China
- HL
Haoran Li
Department of Pharmacology, China
- WZ
Wenyou Zhang
Department of Pharmacology, China
- HH
Hao Han
Department of Pharmacology, China
- MZ
Ming Zhang
Department of Pharmacology, China
- LC
Li Chen
Department of Pharmacology, China
3,875 views
13 citations
13 Authors
- XD
Xiaoqiong Ding
Department of Otorhinolaryngology-Head and Neck Surgery, China
- YH
Yangnan Hu
State Key Laboratory of Bioelectronics, China
- HC
Hong Cheng
State Key Laboratory of Bioelectronics, China
- XZ
Xiaoli Zhang
Department of Otorhinolaryngology-Head and Neck Surgery, China
- LL
Ling Lu
Department of Otorhinolaryngology-Head and Neck Surgery, China
- SG
Song Gao
Department of Otorhinolaryngology-Head and Neck Surgery, China
- CC
Cheng Cheng
Department of Otorhinolaryngology-Head and Neck Surgery, China
- LW
Lifen Wang
Department of Otorhinolaryngology-Head and Neck Surgery, China
- XQ
Xiaoyun Qian
Department of Otorhinolaryngology-Head and Neck Surgery, China
- CZ
Chen Zhang
Beijing Key Laboratory of Neural Regeneration and Repair, China
- RC
Renjie Chai
Department of Otorhinolaryngology-Head and Neck Surgery, China
- XG
Xia Gao
Department of Otorhinolaryngology-Head and Neck Surgery, China
- ZH
Zhichun Huang
Department of Otorhinolaryngology-Head and Neck Surgery, China
5,026 views
9 citations
10 Authors
- MJ
Mingyue Jiang
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- LC
Le Chen
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- BC
Bo Chen
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- QY
Qinghua Yu
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- XZ
Xianming Zhang
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- WJ
Weihong Jing
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- LM
Limei Ma
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- TD
Tao Deng
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- ZY
Zhangyou Yang
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
- CY
Chao Yu
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, China
2,629 views
2 citations
6 Authors
- CL
Chenqi Luo
Eye Center of the Second Affiliated Hospital, China
- HW
Hanle Wang
Eye Center of the Second Affiliated Hospital, China
- XC
Xinyi Chen
Eye Center of the Second Affiliated Hospital, China
- JX
Jingjie Xu
Eye Center of the Second Affiliated Hospital, China
- HY
Houfa Yin
Eye Center of the Second Affiliated Hospital, China
- KY
Ke Yao
Eye Center of the Second Affiliated Hospital, China
7 Authors
- LX
Lin Xia
State Key Laboratory of Bioelectronics, China
- CZ
Chen Zhang
Beijing Key Laboratory of Neural Regeneration and Repair, China
- KS
Kaiming Su
Department of Otolaryngology-Head and Neck Surgery, China
- JF
Jiangang Fan
Department of Otolaryngology Head and Neck Surgery, China
- YN
Yuguang Niu
Department of Ambulatory Medicine, China
- YY
Yafeng Yu
Department of Otolaryngology, China
- RC
Renjie Chai
State Key Laboratory of Bioelectronics, China
2,913 views
6 citations



